GGrantIndex
← Leaderboards

Eugene C. Somoza

University Of Cincinnati

$36,549,732
Attributed
$36,549,732
Total exposure
4
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $4.8M · FY200512
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12

Funding mix

By agency

NIH$36,549,732 · 4

By mechanism

U10$33,598,102 · 1
N01$1,750,323 · 1
R01$792,842 · 1
U19$408,465 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Cincinnati

Same institution · by research overlap

Others in their field

Top investigators on “Training

Research focus

TrainingClinical TrialsResearch PersonnelNational Institute Of Drug AbuseMonitorPharmaceutical PreparationsReportingResponseInnovationProgramsCostUniversitiesLettersStructureProceduresProtocols DocumentationEvidence Based PracticeDrug AbuseResearch TrainingParticipantClinical Trials NetworkKentuckyOhioAids/Hiv Problem

Grant awards (37)

Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site$128,412
R01 · FY2012 · DA · contact PI
Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site$302,495
R01 · FY2011 · DA · contact PI
Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site$78,435
R01 · FY2011 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$1,634,717
U10 · FY2010 · DA · contact PI
Clinical Trials Network, Ohio Valley Node U10DA013732$1,172,875
U10 · FY2010 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$1,042,958
U10 · FY2010 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$8,130
U10 · FY2010 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$1,386,898
U10 · FY2009 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$1,000,000
U10 · FY2009 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$846,441
U10 · FY2009 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$164,294
U10 · FY2009 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$87,160
U10 · FY2009 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$1,873,233
U10 · FY2008 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$1,250,000
U10 · FY2008 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$1,250,000
U10 · FY2008 · DA · contact PI
Multisite Controlled Trial of Cocaine Vaccine (2 of 6) Cincinnati Treatment Site$283,500
R01 · FY2008 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$2,634,865
U10 · FY2007 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$1,250,000
U10 · FY2007 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$950,000
U10 · FY2007 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$1,833,565
U10 · FY2006 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$1,250,000
U10 · FY2006 · DA · contact PI
Clinical Trials Network, Ohio Valley Node$1,250,713
U10 · FY2005 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE$1,208,649
U10 · FY2005 · DA
Clinical Trials Network, Ohio Valley Node$674,975
U10 · FY2005 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE$400,000
U10 · FY2005 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE$1,500,000
U10 · FY2004 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE$1,500,000
U10 · FY2003 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE$920,000
U10 · FY2003 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE$8,628
U10 · FY2003 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE$1,800,000
U10 · FY2002 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE$300,001
U10 · FY2002 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE$2,200,000
U10 · FY2001 · DA
PHASE 1 SAFETY TRIALS--HUMAN MONOCLONAL ANTI-COCAINE ANTIBODY$0
U19 · FY2001 · DA
CLINICAL TRIALS NETWORK, OHIO VALLEY NODE$2,200,000
U10 · FY2000 · DA
0CLINICAL TRIAL OPERATIONS$1,750,323
N01 · FY2000 · DA
PHASE 1 SAFETY TRIALS--HUMAN MONOCLONAL ANTI-COCAINE ANTIBODY$408,465
U19 · FY2000 · DA
0CLINICAL TRIAL OPERATIONS$0
N01 · FY2000 · DA